(Q43727975)

26 November 2017

Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells (English)

1 reference

26 November 2017

Andriani F

1

1 reference

26 November 2017

Nan B

2

1 reference

26 November 2017

Yu J

3

1 reference

26 November 2017

Li X

4

1 reference

26 November 2017

Weigel NL

5

1 reference

26 November 2017

McPhaul MJ

6

1 reference

26 November 2017

Kasper S

7

1 reference

26 November 2017

Kagawa S

8

1 reference

26 November 2017

Fang B

9

1 reference

26 November 2017

Matusik RJ

10

1 reference

26 November 2017

Denner L

11

1 reference

26 November 2017

Marcelli M

12

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Journal of the National Cancer Institute

26 November 2017

1 reference

26 November 2017

93

1 reference

26 November 2017

1314-1324

1 reference

26 November 2017

17

1 reference

Induction of apoptosis in BPH stromal cells by adenoviral-mediated overexpression of caspase-7.

26 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

In vivo expression of prostate-specific adenoviral vectors in a canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Characterization and expression of a cDNA encoding the human androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Characterization of IIB-MEL-J: a new and highly heterogenous human melanoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Establishment of a continuous tumor-cell line (PANC-1) from a human carcinoma of the exocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Role of BAX in the apoptotic response to anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

Androgen receptors in endocrine-therapy-resistant human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.17.1314

21 January 2018

Identifiers

DOI

10.1093/JNCI/93.17.1314

1 reference

26 November 2017

1 reference